Dr. Sameh Al-Zubiedi is an associate Professor of Pharmacology and Therapeutics at the School of Pharmacy, University of Jordan and is the founder and acting director of the University of Jordan Pharmacovigilance office. He is currently a member of the national Pharmacovigilance and Adverse events following immunization (AEFI) review committee in Jordan. He has contributed to several committees at Jordanian Food and Drug Administration (JFDA) such as health hazard evaluation committee, re-registration committee, and clinical studies committees. He is a member of ISOP Middle East Chapter Scientific committee, ISOP 2021 Annual meeting local organizing committee, and WHO Global Patient Safety Network.

Dr. AlZubiedi holds a bachelor degree in pharmacy from Jordan University of Science and Technology (JUST), a master degree (medical sciences) in Clinical Pharmacology from the University of Glasgow and a PhD in pharmacology and Therapeutics from the University of Liverpool funded by UK department of Health. Dr.Al-Zubiedi was a Postgraduate research scientist at Department of Pharmacology and Therapeutics (The University of Liverpool) and the Royal Liverpool and Broadgreen University Hospital NHS Trust.

Dr. Al-Zubiedi was awarded the Daniel Turnberg Traveling Fellowship from UK Academy of Medical Sciences which he spent at the Wolfson Centre for Personalized Medicine, University of Liverpool. Also he was awarded an Erasmus

+ mobility grant from the University of Bath UK and the Menarini Foundation travel fellowship from Italy. Dr-Al.-Zubiedi has participated in several national, regional, and international meetings, workshops, and conferences.

His area on research interests includes pharmacogenetics, pharmacovigilance and medication safety in special population.